Abstract
Objective: To evaluate the effect of parental smoking on childhood acute lymphoblastic leukemia and to determine if it is modified by child genetic polymorphisms.
Methods: We carried out a case–control study in Québec, Canada, including 491 incident cases aged 0–9 years and as many healthy controls matched on age and sex. Each parent was interviewed separately with respect to smoking habits during and after pregnancy. In addition, we carried out a case-only substudy with 158 cases classified according to presence or absence of the alleles *2A, *2B, and *4 in the CYP1A1 gene.
Results: There were small risk increases with maternal smoking during the later trimesters. Interaction odds ratios were increased (although often not significantly) for the CYP1A1*4 allele at high levels of maternal smoking in the last trimesters and at low level of paternal postnatal smoking, and decreased for the CYP1A1*2B allele. The latter appeared to confer a protective advantage at low levels for maternal prenatal smoking and at high levels for paternal postnatal smoking.
Conclusions: Reported smoking habits showed no association with leukemia; risks for genetic polymorphisms lacked precision but indicated that the effect of parental smoking could be modified by variant alleles in the CYP1A1 gene.
Similar content being viewed by others
References
California Environmental Protection Agency (1997) Office of Environmental Health Hazard Assessment. Health Effects of Exposure to Environmental Tobacco Smoke. Final Report, September.
Trédaniel J, Boffetta P, Little J, Saracci R, Hirsch A (1994) Exposure to passive smoking during pregnancy and childhood, and cancer risk: the epidemiological evidence. Paediatr Perinat Epidemiol 8: 233–255.
Brondum J, Shu XO, Steinbuch M, Severson RK, Potter JD, Robison LL (1999) Parental cigarette smoking and the risk of acute leukemia in children. Cancer 85: 1380–1388.
Hirnoven A (1999) Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environ Health Perspect 107(Suppl. 1): 37–47.
Smith G, Stanley LA, Sim E, Strange RC, Wolf CR (1995) Metabolic polymorphisms and cancer susceptibility. Cancer Surv 25: 27–65.
Shimada T, Yun CH, Yamazaki H, Gautier JC, Beaume PH, Guengerich FP (1992) Characterization of human lung microsomal cytochrome P450 1A1 and its role in oxidation of chemical carcinogens. Mol Pharmacol 41: 856–864.
Guengerich FP, Shimada T (1998) Activation of procarcinogens by human cytochrome P450 enzymes. Mutat Res 400: 201–213.
US Department of Health and Human Services (1998) The Eighth Report on Carcinogens. Public Health Service, National Toxicology Program.
Juchau MR, Boutelet-Bochan H, Huang Y (1998) Cytochrome-P450-dependent biotransformation of xenobiotics in human and rodent embryonic tissues. Drug Metab Rev 30: 541–568.
Hakkola J, Pelkonen O, Pasanen M, Raunio H (1998) Xenobiotic-metabolizing cytochrome P450 enzymes in the human fetoplacental unit: role in intrauterine toxicity. Crit Rev Toxicol 28: 35–72.
Whyatt RM, Bell DA, Jedrychowski W, et al. (1998) Polycyclic aromatic hydrocarbon-DNA adducts in human placenta and modulation by CYP1A1 induction and genotype. Carcinogenesis 19: 1389–1392.
Krajinovic M, Labuda D, Richer C, Karimi S, Sinnett D (1999) Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood 93: 1496–1501.
Infante-Rivard C, Labuda D, Krajinovic M, Sinnett D (1999) Risk of childhood leukemia associated with exposure to pesticides and with gene polymorphisms. Epidemiology 10: 481–487.
Piegorsch WW, Weinberg CR, Taylor JA (1994) Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat Med 13: 153–162.
Begg CB, Zhang ZF (1994) Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev 3: 173–175.
Khoury MJ, Flanders WD (1996) Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am J Epidemiol 144: 207–213.
Baccichet A, Qualman SK, Sinnett D (1997) Allelic loss in childhood acute lymphoblastic leukemia. Leuk Res 21: 817–823.
Cascorbi I, Brockmuller J, Roots I (1996) A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res 56: 4965–4969.
Sorahan T, Lancashire RJ, Hultén MA, Stewart AM (1997) Childhood cancer and parental use of tobacco: deaths from 1953 to 1955. Br J Cancer 75: 134–138.
Ji BT, Shu XO, Linet MS, et al. (1997) Paternal cigarette smoking and the risk of childhood cancer among offspring of nonsmoking mothers. J Natl Cancer Inst 89: 251–256.
Aubin J, Caouette L (1998) L’usage de la cigarette au Québec de 1985 à 1994: une comparaison avec le Canada. Can J Public Health 89: 22–27.
Santé-Canada (1999) Le tabagisme au Canada durant les 16 derniéres années. Promotion de la santé en direct.
Infante-Rivard C, Jacques L (2000) An empirical study of parental recall bias. Am J Epidemiol (In press).
Dellacro VL, Kimmel CA (1997) Risk assessment of environmental agents for developmental toxicity: current and emerging approaches. Mutat Res 396: 205–218.
Crofts F, Taioli E, Trachman J, et al. (1994) Functional significance of different human CYP1A1 genotypes. Carcinogenesis 15: 2961–2963.
Landi MT, Bertazzi PA, Shields PG, et al. (1994) Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 4: 242–246.
Zhang ZY, Fasco MJ, Huang L, Guengerich FP, Kaminski LS (1996) Characterization of purified human recombinant cytochrome P450 1A1-Ile462 and-Val462: assessment of a role for the rare allele in carcinogenesis. Cancer Res 56: 3926–3933.
Rumsby PC, Yardley-Jones A, Anderson D, Phillimore HE, Davies MJ (1996) Detection of CYP1A1 mRNA levels and CYP1A1 Msp 1 polymorphisms as possible biomarkers of exposure and susceptibility in smokers and non-smokers. Teratog Carcinog Mutagen 16: 65–74.
Watanabe M (1998) Polymorphic CYP genes and disease predisposition-what have the studies shown so far? Toxicol Lett 102-103: 167–171.
d'Errico A, Malats N, Vineis P, Boffetta P (1999) Review of studies of selected metabolic polymorphisms and cancer. In: Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Boffetta P, eds. Metabolic Polymorphisms and Susceptibility to Cancer. Lyon: IARC Scientific Publications No. 148, pp. 323–393.
Gotoh O, Tagashira Y, Iizuka T, Fujii-Kuriyama Y (1983) Structural characteristics of cytochrome P-450. Possible location of the heme-binding cysteine in determined amino-acid sequences. J Biochem (Tokyo) 93: 807–817.
Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S (1993) The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol 14: 77–87.
Bailey LR, Roodi N, Verrier CS, Yee CJ, Dupont WD, Parl FF (1998) Breast cancer and CYP1A1, GSTM1, GSTT1, polymorphism: evidence of a lack of association in Caucasian and African Americans. Cancer Res 58: 65–70.
Esteller M, Garcia A, Martinez-Palones JP, Xercavins J, Reventos J (1997) Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis 18: 2307–2311.
Bolande RP (1999) Prenatal exposures and childhood cancer. Pediatr Dev Pathol 2: 208–214.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Infante-Rivard, C., Krajinovic, M., Labuda, D. et al. Parental smoking, CYP1A1 genetic polymorphisms and childhood leukemia (Québec, Canada). Cancer Causes Control 11, 547–553 (2000). https://doi.org/10.1023/A:1008976116512
Issue Date:
DOI: https://doi.org/10.1023/A:1008976116512